Exploration of α1-Antitrypsin Treatment Protocol for Islet Transplantation: Dosing Plan and Route of Administration

Lifelong weekly infusions of human α1-antitrypsin (hAAT) are currently administered as augmentation therapy for patients with genetic AAT deficiency (AATD). Several recent clinical trials attempt to extend hAAT therapy to conditions outside AATD, including type 1 diabetes. Because the endpoint for A...

Descripción completa

Detalles Bibliográficos
Autores principales: Baranovski, Boris M., Ozeri, Eyal, Shahaf, Galit, Ochayon, David E., Schuster, Ronen, Bahar, Nofar, Kalay, Noa, Cal, Pablo, Mizrahi, Mark I., Nisim, Omer, Strauss, Pnina, Schenker, Eran, Lewis, Eli C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society for Pharmacology and Experimental Therapeutics 2016
Materias:
Inflammation, Immunopharmacology, and Asthma
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5118642/
https://www.ncbi.nlm.nih.gov/pubmed/27821710
http://dx.doi.org/10.1124/jpet.116.236067

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5118642/
https://www.ncbi.nlm.nih.gov/pubmed/27821710
http://dx.doi.org/10.1124/jpet.116.236067

Ejemplares similares